Drug – bio-affecting and body treating compositions – Plural fermentates of different origin
Patent
1980-12-09
1984-02-21
Rizzo, Nicholas S.
Drug, bio-affecting and body treating compositions
Plural fermentates of different origin
2602452R, 424270, 424271, C07D49900, A61K 31425
Patent
active
044329709
ABSTRACT:
6-beta-Halopenicillanic acid 1,1-dioxides, physiologically acceptable salts thereof and esters thereof readily hydrolyzable; pharmaceutical compositions containing a 6-beta-halopenicillanic acid 1,1-dioxide, a physiologically acceptable salt thereof or an ester thereof readily hydrolyzable; and a method for enhancing the effectiveness of a beta-lactam antibiotic, using a 6-beta-halopenicillanic acid 1,1-dioxide, a physiologically acceptable salt thereof or an ester thereof readily hydrolyzable.
REFERENCES:
patent: 3197466 (1965-07-01), Chow et al.
patent: 3741959 (1973-06-01), Looker et al.
patent: 4180506 (1979-12-01), Pratt
patent: 4203993 (1980-05-01), Gordon
patent: 4272439 (1981-06-01), Ganguly et al.
Harrison et al., Journal of the Chemical Society (London), Perkin I, 1772 (1976).
Busson et al., "Recent Advances in the Chemistry of Beta-Lactam Antibiotics", J. Elks, ed., Burlington House, London, 1977, Chapter 32, pp. 304-313.
Clayton, Journal of the Chemical Society (London), Part C, 2123 (1969).
Daehne, Journal of Antibiotics, 33, 451, (1980).
Cartwright et al., Nature, 278, 360, (1979).
Pfizer Inc.
Rizzo Nicholas S.
LandOfFree
6-beta-Halopenicillanic acid 1,1-dioxides as beta-lactamase inhi does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 6-beta-Halopenicillanic acid 1,1-dioxides as beta-lactamase inhi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 6-beta-Halopenicillanic acid 1,1-dioxides as beta-lactamase inhi will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1035401